ANNAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc.,
(Amex: PIP) a biodefense company developing medical countermeasures against
biological and chemical threats, announced today that David P. Wright,
President and Chief Executive Officer of PharmAthene, will present at the
Cowen and Company 28th Annual Health Care Conference in Boston on Tuesday,
March 18, 2008 at 8:45 a.m. The presentation is scheduled to take place in
the Vineyard Room at the Boston Marriott Copley Place hotel.
PharmAthene's presentation will be available via webcast on the
company's website at http://www.pharmathene.com. A link to access the
webcast will be accessible from both the homepage and the investor
relations pages of the PharmAthene corporate website. For assistance,
contact Stacey Jurchison at 410-269-2610.
About PharmAthene, Inc.
PharmAthene (Amex: PIP) was formed to meet the critical needs of the
United States and its allies by developing and commercializing medical
countermeasures against biological and chemical weapons. PharmAthene's lead
programs include Valortim(TM) for the prevention and treatment of anthrax
infection and Protexia(R) for the prevention and treatment of morbidity and
mortality associated with exposure to chemical nerve agents. For more
information on PharmAthene, please visit http://www.pharmathene.com.
SOURCE PharmAthene, Inc.
 back to top
Related links:
http://www.pharmathene.com
CONTACT:
Stacey Jurchison, Director, Corporate
Communications of PharmAthene, Inc., +1-410-269-2610, or mobile,
+1-410-474-8200, JurchisonS@PharmAthene.com
|
